Effect of dental treatment on chewing ability and mental health in patients with severe gum disease
Impact of Subgingival Instrumentation on Masticatory Performance and Psychological Distress in Periodontitis: Stage III and IV
This study tests if dental treatment for severe gum disease can improve chewing ability and mental health in people aged 30-50.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 92 (estimated) |
| Ages | 30 Years to 50 Years |
| Sex | All |
| Sponsor | Postgraduate Institute of Dental Sciences Rohtak Academic / other |
| Locations | 1 site (Rohtak, Haryana) |
| Trial ID | NCT06024447 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the impact of subgingival instrumentation on masticatory performance and psychological distress in patients with Stage III and IV periodontitis. Participants aged 30-50 with a minimum of 20 teeth will undergo treatment and be assessed for changes in chewing ability and psychological well-being after 2 and 3 months. The study aims to understand the relationship between periodontal health and its effects on both physical and mental health outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 30-50 diagnosed with Stage III or IV generalized periodontitis and having at least 20 teeth.
Not a fit: Patients with systemic diseases affecting periodontal health or masticatory ability, as well as those with recent periodontal treatment or psychiatric disorders, may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could improve chewing function and reduce psychological distress in patients suffering from severe gum disease.
How similar studies have performed: While the specific approach of this study may be novel, existing literature suggests that improving periodontal health can positively influence masticatory function and psychological well-being.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with age group 30-50 years diagnosed with stage III/IV generalized periodontitis. * Presence of minimum 20 teeth (Eichner group A1, A2, A3) excluding third molars. Exclusion Criteria: * Systemic diseases that may affect periodontal disease progression or outcome of treatment (diabetes, autoimmune diseases) * Systemic diseases that may affect masticatory ability of the patient (sarcopenia, TMJ disorders, Xerostomia, Acute Pulpitis) * Periodontal treatment within the 6 months * Patients wearing orthodontic appliances * Any diagnosed psychiatric disorder * Antibiotic use within the previous 3 months * Steroid, immunosuppressive and psychiatric drug use * Pregnant and lactating women * History of menopause * Smoking or substance abuse
Where this trial is running
Rohtak, Haryana
- Post Graduate Institute of Dental Sciences — Rohtak, Haryana, India (Recruiting)
Study contacts
- Principal investigator: Janvi Janvi, BDS — PGIDS Rohtak
- Study coordinator: Sanjay Tewari, MDS
- Email: principalpgids@yahoo.in
- Phone: 91-1262-283876
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.